Investing.com - Jefferies reiterated a Buy rating on Viking Therapeutic (NASDAQ:VKTX) with a $101.00 price target. The stock currently trades at $35.17, up 13% over the past week and 44% over six ...

VIS-101 is a bispecific, tetravalent dual VEGF-A/ANG-2 inhibitor designed to treat wet AMD, diabetic macular edema and retinal vein occlusion. The drug candidate is currently completing a randomized, ...

The Square of 9 geometry places harmonic resistance at $97.30 (recent high), $100.74 (Weekly Sell 2), and $101.53 (Daily Sell 1 overhead extension). A sustained close above $97.31 shifts resistance ...

Gold Futures, Crude Oil WTI Futures, Bitcoin US Dollar, US Dollar Index RT. Read 's Market Analysis on Investing.com ...

Investing.com - U.S. stock futures dropped on Tuesday, as investors gauged ongoing strikes across the Middle East as well as ...

Here’s a roundup of the most significant insider trading activity reported for Thursday, March 26, 2026, across US stock ...

The Lovesac Company (NASDAQ:LOVE) reported fourth quarter results that exceeded analyst expectations on Thursday. The company’s shares were up 18.33% in pre-ma ...

Kodiak Sciences Inc. reports fourth-quarter 2025 results Thursday, as the pre-commercial biotech seeks to narrow losses while ...

Absci Corporation (NASDAQ:ABSI) reported fourth quarter results that fell short of analyst expectations, with shares ...

European stocks rise and oil climbs as worries around Iran war persist ...

Investing.com -- Swiss laboratory automation company Tecan Group swung to a full-year net loss of CHF 110.7 million in 2025 ...

British stocks extended losses on Thursday after the Bank of England held rates at 3.75% as expected, while the pound edged ...